[JCR Pharma] Share Buyback and Incentive Scheme ｜ June 2026

Overview of the Sale

JCR Pharma will sell 216,000 shares of treasury stock at 456 yen per share on July 22, 2026. This sale is based on a restricted stock compensation scheme and aims to enhance incentives for directors and employees. The total amount of the sale is 98,496,000 yen, with 11 directors, 9 executive officers, and 3 employees as the targets. The sale is conducted based on the market stock price, with detailed regulations on the framework of the scheme and methods for managing the shares.

Purpose of the Scheme and Future Outlook

This scheme aims for sustainable enhancement of corporate value and value sharing with shareholders. By granting shares to the targeted individuals, motivation is increased. The sold shares are subject to a certain period of transfer restrictions and will be released in accordance with conditions upon resignation or organizational reorganization. The company will continue to operate the scheme to promote management incentives and corporate growth.